Efficient silencing of bcr/abl oncogene by single- and double-stranded siRNAs targeted against b2a2 transcripts

Biochemistry

Volumn 43, Issue 51, 2004, Pages 16134-16141

  Rapozzi, Valentina ^a   Xodo, Luigi Emilio ^a  

^a Section of Oncology and Molecular Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CARCINOGENS; CELLS; GROWTH (MATERIALS); STABILITY;

APOPTOSIS; BIOLOGICAL EFFECTS; CELL GROWTH; ONCOGENES;

RNA;

BCR ABL PROTEIN; DOUBLE STRANDED RNA; MESSENGER RNA; PROTEIN P27; SINGLE STRANDED RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BASE PAIRING; BRC ABL GENE; CELL GROWTH; COLONY FORMATION; CONTROLLED STUDY; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; ONCOGENE; PRIORITY JOURNAL; RNA STABILITY;

BASE SEQUENCE; BLOTTING, WESTERN; ELECTROPORATION; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; GENE SILENCING; GENES, ABL; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EUKARYOTA;

EID: 11144318656     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi048634w     Document Type: Article

References (36)

1. Daley, G. Q., van Etten, R. A., and Baltimore, D. (1990) Induction of chromic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome, Science 247, 824-830.
2. Faded, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., and Kantarjian, H. M. (1999) The biology of chronic myeloid leukemia, New Engl. J. Med. 241, 164-172.
3. Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., and Sawyers, C. L. (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia, New Engl. J. Med. 344, 1031-1037.
4. Nowell, P. C., and Hungerford, D. A. (1960) A minute chromosome in human chronic granulocytic leukaemia, Science 132, 1497.
5. Rowley, J. D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining, Nature 243, 290-293.
6. Kurzrock, R., Gutterman, J. U., and Talpaz, M. (1988) The molecular genetics of Philadelphia-positive leukaemias, New Engl. J. Med. 319, 990-998.
7. Goldman, J. M., and Melo, J. V. (2003) Chronic myeloid leukemia - Advances in biology and new approaches to treatment, New Engl. J. Med. 349, 1451-1464.
8. Bhatia, R., and Verfaillie, C. M. (1998) Inhibition of BCR/ABL expression with antisense oligodeoxynucletides restore b1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous hematopoietic progenitors, Blood 91, 3114-3422.
9. Clark, R. E. (2000) Antisense therapeutics in chronic myeloid leukaemia: The promise, the progress, and the problems, Leukemia 14, 347-355.
10. Maran, A., Waller, C. F., Paranjape, J. M., Li, G., Xiao, W., Zhang, K., Kalaycio, M. E., Maitra, R. K., Lichtin, A. E., Brugger, W., Torrence, P. F., and Silverman, R. H. (1998) 2′,5′-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells, Blood 92, 4336-4343.
11. Kato, Y., Kuwabara, T., Toda, H., Warashina, M., and Taira, K. (2000) Suppression of BCR-ABL mRNA by various ribozymes in HeLa cells, Nucleic Acids Symp. Ser. 44, 283-284.
12. Rapozzi, V., Burm, E. A., Cogoi, S., van der Marel, G. A., van Boom, J. H., Quadrifoglio, F., and Xodo, L. E. (2002) Antiproliferative effect in chronic myeloid leukemia cells by antisense peptide nucleic acids, Nucleic Acids Res. 30, 3712-3721.
13. Rapozzi, V., Cogoi, S., Spessotto, P., Risso, A., Bonora, G. M., Quadrifoglio, F., and Xodo, L. E. (2002) Antigene effect in K562 cells of a PEG-conjugated triplex. Forming oligonucleotide targeted to the bcr/abl oncogene, Biochemistry 41, 502-510.
14. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature 411, 494-498.
15. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature 391, 806-811.
16. Hammond, S. M., Bernstein, E., Beach, D., and Hannon, G. J. (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells, Nature 404, 293-296.
17. Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. (2000) RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals, Cell 101, 25-33.
18. Wilda, M., Fuchs, U., Wossmann, W., and Borkhardt, A. (2002) Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi), Oncogene 21, 5716-5724.
19. Scherr, M, Battmer, K., Winkler, T., Heidenreich, O., Ganser, A., and Eder, M. (2003) Specific inhibition of bcr/abl gene expression by small intereference RNA, Blood 101, 1566-1569.
20. Wholbold, L., van der Kuip, H., Miething, C., Vorlocher, H.-P., Knabbe, C., Duyster, J., and Aulitzy, W. E. (2003) Inhibition of bcr/abl gene expression by small interference RNA sensitises for imatinib mesylate (STI571), Blood 102, 2236-2239.
21. Melo, J. V. (1996) The molecular biology of chronic myeloid leukaemia, Leukemia 10, 751-756.
22. Moravcova, J., Lukasova, M., Stary, J., and Haskovec, C. (1998) Simple competitive two-step RT-PCR assay to monitor minimal residual disease in CML patients after bone marrow transplantation, Leukemia 12, 1303-1312.
23. Markwell, M. A., Haas, S. M., Bieber, L. L., and Tolbert, N. E (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples, Anal. Biochem. 87, 206-210.
24. Xodo, L., Alunni-Fabbroni, M., Manzini, G., and Quadrifoglio, F. (1994) Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition, Nucleic Acids Res. 22, 3322-3330.
25. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., and Tuschl, T. (2002) Single-stranded antisense siRNAs guide target RNA cleavage in RNAi, Cell 110, 563-574.
26. Spiller, D. G., Giles, R. V., Broughton, C. M., Grzybowski, J., Ruddell, C. J., Tidd, D. M., and Clarke, R. E. (1998) The influence of target protein half-life on the effectivenesse of antisense oligonucleotide analogue-mediated biological response, Antisense Nucleic Acid Drug Dev. 8, 281-293.
27. Holen, T., Amarzguioui, M., Babaie, E., and Prydz, H. (2003) Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway, Nucleic Acids Res. 31, 2401-2407.
28. Gesbert, F., Sellers, W. R., Signoretti, S., Loda, M., and Griffin, J. D. (2000) BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-kinase/AKT pathway, J. Biol. Chem. 275, 39223-39230.
29. Jonuleit, T., van der Kuip, H., Miething, C., Michels, H., Hallek, M., Duyster, J., and Aulitzky, W. E. (2000) BCR-ABL kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines, Blood 96, 1933-1939.
30. Khvorova, A., Reynolds, A., and Jayasena, S. D. (2003) Functional siRNAs and miRNAs exhibit strand bias, Cell 115, 209-216.
31. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., and Khvorova, A. (2004) Rational siRNA design for RNA interference, Nat. Biotechnol. 22, 326-330.
32. Ui-Tei, K., Naito, Y., Taakahashi, F., Haraguchi, T., Ohki-Hamazashi, T., Ohki-Hamazaki, H., Juni, A., Ueda, R., and Saigo, K. (2004) Guidelines for the selection of highly effective siRNA sequences for mammalian and chick interference, Nucleic Acids Res. 32, 936-948.
33. Freier, S. M., Kierzek, R., Jaeger, J. A., Sugimoto, N., Caruthers, M. H., Neilson, T., and Turner, D. H. (1986) Improved free-energy parameters for predictions of RNA duplex stability, Proc. Natl. Acad. Sci. U.S.A. 83, 9373-9377.
34. McGahon, A., Bissonette, R., Schmitt, M., Cotter, K. M., Green, D. R., and Cotter, T. G. (1994) BCR-ABL maintains resistance to chronic myelogenous leukaemia cells to apoptotic cells death, Blood 83, 1179-1187.
35. Warmuth, M., Danhauser-Riedel, S., and Hallek, M. (1999) Molecular pathogenesis of chronic myeloid leukaemia: Implications for new therapeutic strategies, Ann. Hematol. 78, 49-64
36. Mahon, F. X., Deininger, M. W., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J. M., and Melo, J. V. (2000) Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance, Blood 96, 1070-1079.